285 related articles for article (PubMed ID: 18625635)
1. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
3. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
4. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
6. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
[TBL] [Abstract][Full Text] [Related]
7. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
8. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
10. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
11. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
[TBL] [Abstract][Full Text] [Related]
13. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
Mejri N; Gottstein B
Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
[TBL] [Abstract][Full Text] [Related]
15. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in patients with systemic lupus erythematosus.
Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
[TBL] [Abstract][Full Text] [Related]
17. Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus.
Miyamoto M; Ono E; Barbosa C; Terreri M; Hilário M; Salomão R; de Moraes-Pinto M
Lupus; 2011 Jun; 20(7):736-44. PubMed ID: 21505013
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients.
Hamzaoui A; Chaouch N; Graïri H; Ammar J; Hamzaoui K
Mediators Inflamm; 2005 Aug; 2005(3):160-6. PubMed ID: 16106102
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
[TBL] [Abstract][Full Text] [Related]
20. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
